- Home
- ALVO vs PJT Comparison
ALVO vs PJT Comparison
Compare ALVO & PJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVO
- PJT
- Stock Information
- Founded
- ALVO 2013
- PJT 2014
- Country
- ALVO Luxembourg
- PJT United States
- Employees
- ALVO N/A
- PJT N/A
- Industry
- ALVO Biotechnology: Pharmaceutical Preparations
- PJT Investment Managers
- Sector
- ALVO Health Care
- PJT Finance
- Exchange
- ALVO Nasdaq
- PJT Nasdaq
- Market Cap
- ALVO 4.0B
- PJT 3.8B
- IPO Year
- ALVO N/A
- PJT N/A
- Fundamental
- Price
- ALVO $12.44
- PJT $173.62
- Analyst Decision
- ALVO Buy
- PJT Hold
- Analyst Count
- ALVO 1
- PJT 5
- Target Price
- ALVO $18.00
- PJT $141.75
- AVG Volume (30 Days)
- ALVO 193.2K
- PJT 217.4K
- Earning Date
- ALVO 03-19-2025
- PJT 02-04-2025
- Dividend Yield
- ALVO N/A
- PJT 0.57%
- EPS Growth
- ALVO N/A
- PJT 57.50
- EPS
- ALVO N/A
- PJT 4.92
- Revenue
- ALVO $393,919,000.00
- PJT $1,493,177,000.00
- Revenue This Year
- ALVO $398.12
- PJT $21.99
- Revenue Next Year
- ALVO $44.73
- PJT $13.68
- P/E Ratio
- ALVO N/A
- PJT $35.32
- Revenue Growth
- ALVO 517.92
- PJT 29.09
- 52 Week Low
- ALVO $9.15
- PJT $88.51
- 52 Week High
- ALVO $18.00
- PJT $190.24
- Technical
- Relative Strength Index (RSI)
- ALVO 42.13
- PJT 66.43
- Support Level
- ALVO $12.36
- PJT $159.42
- Resistance Level
- ALVO $12.96
- PJT $167.53
- Average True Range (ATR)
- ALVO 0.35
- PJT 4.92
- MACD
- ALVO -0.13
- PJT 0.97
- Stochastic Oscillator
- ALVO 27.15
- PJT 48.07
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.
About PJT PJT Partners Inc.
PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement fees, and others. Geographically, It generates a majority of its revenue from the United States.